Collectively, our data suggest that LSD1 is a mediator of drug resistance in breast cancer cells and establish it as a key regulator of cancer stemness, since it affects the self-renewal and tumor-initiation capacity of bCSCs in vitro and in vivo. Here, KDM1A is linked to breast cancer.